Similar articles

• The place of fecal occult blood test in colorectal cancer screening in 2006: the U.S. perspective.

  Bond JH. Bond JH. Am J Gastroenterol. 2006 Feb;101(2):219-21. doi: 10.1111/j.1572-0241.2006.00486.x. Am J Gastroenterol. 2006. PMID: 16454821 No abstract available.
• The effect of fecal occult-blood screening on the incidence of colorectal cancer.

  Allison JE. Allison JE. N Engl J Med. 2001 Mar 29;344(13):1022; author reply 1023. N Engl J Med. 2001. PMID: 11280326 No abstract available.
• Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.

  Heitman SJ, Au F, Manns BJ, McGregor SE, Hilsden RJ. Heitman SJ, et al. Clin Gastroenterol Hepatol. 2008 Aug;6(8):912-917.e1. doi: 10.1016/j.cgh.2008.03.006. Epub 2008 Jun 5. Clin Gastroenterol Hepatol. 2008. PMID: 18534918
• [Screening the population for colorectal cancer: the background to a number of pilot studies in the Netherlands].

  van Rijn AF, Dekker E, Kleibeuker JH. van Rijn AF, et al. Ned Tijdschr Geneeskd. 2006 Dec 16;150(50):2739-44. Ned Tijdschr Geneeskd. 2006. PMID: 17225784 Review. Dutch.
• Colorectal cancer screening: a guide to the guidelines.

  Deenadayalu VP, Rex DK. Deenadayalu VP, et al. Rev Gastroenterol Disord. 2007 Fall;7(4):204-13. Rev Gastroenterol Disord. 2007. PMID: 18192956 Review.